The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, 'eve') on body temperature and long term degeneration of 5-HT neurones in brain: A comparison with MDMA ('ecstasy')

Pharmacology and Toxicology

Volumn 84, Issue 6, 1999, Pages 261-266

  Colado, Maria Isabel ^a   Granados, Raquel ^a   O'Shea, Esther ^a   Esteban, Blanca ^a   Green, A Richard ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; INDOLE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; PAROXETINE; SEROTONIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRAIN CORTEX; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; HIPPOCAMPUS; HYPERTHERMIA; MALE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; SEROTONIN BRAIN LEVEL; TOXICITY TESTING;

EID: 0033044205     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1999.tb01492.x     Document Type: Article

References (26)

1. Ali, S. F., G. D. Newport, A. C. Scallet, Z. Binienda, S. A. Ferguson, J. R. Bailey, M. G. Paule & W. Slikker Jr: Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the non-human primate. Neurotoxicol. Teratol. 1993, 15, 91-96.
2. Broening, H. W., J. F. Bowyer & W. Slikker, Jr.: Age dependent sensitivity of rats to the long term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J. Pharmacol. Exp. Therap. 1995, 275, 325-333.
3. Colado, M. I., E. O'Shea, R. Granados, T. K. Murray, J. L. Williams & A. R. Green: In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ("Ecstasy") and p-chloroamphetamine but not the degeneration following fenfluramine. Brit. J. Pharmacol. 1997, 121, 889-900.
4. Colado, M. I., J. L. Williams & A. R. Green: The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metaboliser phenotype. Brit. J. Pharmacol. 1995, 115, 1281-1289.
5. Dowling, G. P., E. T. McDonough 3rd & R. O. Bost: "Eve" and "Ecstasy". A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987, 257, 1515-1517.
6. Farfel, C. M. & L. S. Seiden: Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments with 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J. Pharmacol. Exp. Therap. 1995, 272, 868-875.
7. Fineschi, V. & A. Masti: Fatal poisoning by MDMA (ecstasy) and MDEA: a case report. Int. J. Legal Med. 1996, 108, 272-275.
8. Gouzoulis-Mayfrank, E., L. Hermle, K. A. Kovar & H. Sass: Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substance among illegal designer drugs? Nervenarzt. 1996, 67, 369-380.
9. Green, A. R. & G. M. Goodwin: Ecstasy and neurodegeneration. Brit. Med. J. 1996, 312, 1493-1494.
10. Green, A. R., A. J. Cross & G. M. Goodwin: Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy') (Review). Psychopharmacology 1995, 119, 247-260.
11. Henry, J. A., K. J. Jeffreys & S. Dawling: Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 1992, 340, 384-387.
12. Hewitt, K. E. & A. R. Green: Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy'). Neuropharmacology 1994, 33, 1589-1595.
13. Iwersen, S. & A. Schmoldt: Two very different fatal cases associated with the use of methylenedioxyethylamphetamine (MDEA): Eve as deadly as Adam. J. Toxicol. Clin. Toxicol. 1996, 34, 241-244.
14. Mansbach, R. S., D. L. Braff & M. A. Geyer: Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat. Eur. J. Pharmacol. 1989 167, 49-55.
15. Milroy, C. M., J. C. Clark & A. R. Forrest: Pathology of deaths associated with "ecstasy" and "eve" misuse. J. Clin. Path. 1996, 49, 149-154.
16. Murray, T. K., J. L. Williams, A. Misra, M. I. Colado & A. R. Green: The spin trap reagent PBN attennuates degeneration of 5-HT neurons in rat brain induced by p-chloroamphetamine but not fenfluramine. Neuropharmacology 1996, 35, 1615-1620.
17. O'Shea, E., R. Granados, B. Esteban, M. I. Colado & A. R. Green: The relationship between the degree of neurodegeneration of rat brain 5-HT terminals and the dose and frequency of administration of MDMA ("ecstasy"). Neuropharmacology 1998, 37, 919-926.
18. Paulus, M. P. & M. A. Geyer: The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology 1992, 7, 15-31.
19. Ricaurte, G. A., L. E. Delaney E, I. Irwin & J. W. Langston: Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res. 1988, 446, 165-168.
20. Ricaurte, G. A., K. F. Finnegan, D. E. Nichols, L. E. DeLanney, I. Irwin I. & J. W. Langston: 3,4-Methylene dioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long lasting depletion of serotonin in rat brain. Eur. J. Pharmacol. 1987, 137, 265-268.
21. Schmidt, C. J.: Acute administration of methylenedioxyethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs. Eur. J. Pharmacol. 1987, 136, 81-88.
22. Sternbach, G. L. & J. Varon: "Designer drugs" Recognising and managing their toxic effects. Postgrad. Med. 1992a, 91, 169-171.
23. Sternbach, G. L. & J. Varon: "Designer drugs" Recognising and managing their toxic effects. Postgrad. Med. 1992b, 91, 175-176.
24. Stone, D. M., M. Johnson, G. R. Hanson & G. W. Gibb: A comparison of the neurotoxic potential of methylenedioxyamphetamine and its N-methylated and N-ethylated derivatives. Eur. J. Pharmacol. 1987, 134, 245-248.
25. Tehan, B., R. Harden & A. Bodenham: Hyperthermia associated with 3,4-methylenedioxyethamphetamine ("Eve"). Anaesthesia 1993, 48, 507-510.
26. Tsatsakis, A. M., M. N. Michalodimitrakis & A. N. Patsalis: MDEA related death in Crete: A case report and literature review. Vet. Human Toxicol. 1997, 39, 241-244.